Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP452032.RA0jp_YD8wp07Ecvu3KXrt-GE2nmA8TWa2GSZ-5ZOvfdA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP452032.RA0jp_YD8wp07Ecvu3KXrt-GE2nmA8TWa2GSZ-5ZOvfdA130_assertion type Assertion NP452032.RA0jp_YD8wp07Ecvu3KXrt-GE2nmA8TWa2GSZ-5ZOvfdA130_head.
- NP452032.RA0jp_YD8wp07Ecvu3KXrt-GE2nmA8TWa2GSZ-5ZOvfdA130_assertion wasGeneratedBy ECO_0000203 NP452032.RA0jp_YD8wp07Ecvu3KXrt-GE2nmA8TWa2GSZ-5ZOvfdA130_provenance.
- NP452032.RA0jp_YD8wp07Ecvu3KXrt-GE2nmA8TWa2GSZ-5ZOvfdA130_assertion wasDerivedFrom befree-20150227 NP452032.RA0jp_YD8wp07Ecvu3KXrt-GE2nmA8TWa2GSZ-5ZOvfdA130_provenance.
- NP452032.RA0jp_YD8wp07Ecvu3KXrt-GE2nmA8TWa2GSZ-5ZOvfdA130_assertion SIO_000772 19883394 NP452032.RA0jp_YD8wp07Ecvu3KXrt-GE2nmA8TWa2GSZ-5ZOvfdA130_provenance.
- NP452032.RA0jp_YD8wp07Ecvu3KXrt-GE2nmA8TWa2GSZ-5ZOvfdA130_assertion evidence source_evidence_literature NP452032.RA0jp_YD8wp07Ecvu3KXrt-GE2nmA8TWa2GSZ-5ZOvfdA130_provenance.
- NP452032.RA0jp_YD8wp07Ecvu3KXrt-GE2nmA8TWa2GSZ-5ZOvfdA130_assertion description "[The percentage of promoter methylation was 59.57% for HLA-A gene, 55.32% for HLA-B gene and 48.94% for HLA-C gene in gastric cancer, while it was decreased to 19.15%, 12.77% and 6.38% in the adjacent nontumor tissues, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP452032.RA0jp_YD8wp07Ecvu3KXrt-GE2nmA8TWa2GSZ-5ZOvfdA130_provenance.